Amerinet Signs Agreement with Teleflex Incorporated for VasoNova® VPS® (Vascular Positioning System)

Unique Technology Allows for Real-Time Accurate Confirmation of Catheter Tip Placement

LIMERICK, Pa.--(BUSINESS WIRE)-- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, has announced the addition of VasoNova ®Vascular Positioning System (VPS®) to its existing Peripherally Inserted Central Catheters agreement with Amerinet. The agreement began May 1, 2011 and runs through April 30, 2014.

“This agreement brings a powerful new option for catheter placement confirmation to clinicians,” noted Paul Molloy, President, Vascular Division, Teleflex. “The VasoNova VPS system comprises an advanced electronic console and single use procedure kit. The technology significantly increases correct central catheter tip placement on the first attempt with a goal of reducing the time, cost and radiation exposure associated with confirmatory chest X-rays. We anticipate patients will benefit from faster time to therapy with reduced risk of complications associated with malposition as a result.”

VasoNova recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the VPS peripherally inserted central catheter tip location technology as an alternative to chest x-ray or fluoroscopy in adult patients.

About Amerinet

As a leading national healthcare group purchasing organization, Amerinet collaborates with acute and alternate care providers to create and deliver unique solutions through performance improvement resources, guidance and ongoing support. With better product standardization and utilization, new financial tools beyond contracting and alliances that help lower costs, raise revenue and champion quality, Amerinet enriches healthcare delivery for its members and the communities they serve. To learn more about how Amerinet can help you successfully navigate the future of healthcare reform, visit www.amerinet-gpo.com.

About Teleflex Incorporated

Teleflex is a leading global provider of specialty medical devices for a range of procedures in critical care and surgery. Our mission is to provide solutions that enable healthcare providers to improve outcomes and enhance patient and provider safety. Headquartered in Limerick, PA, Teleflex employs approximately 12,000 people worldwide and serves healthcare providers in more than 130 countries. For additional information about Teleflex, please refer to www.teleflex.com.

Forward-Looking Statements

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management's current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.



CONTACT:

Teleflex Incorporated
Jake Elguicze
Vice President Investor Relations
610-948-2836

KEYWORDS:   United States  North America  Pennsylvania

INDUSTRY KEYWORDS:   Surgery  Health  Hospitals  Medical Devices  Other Health

MEDIA:

Logo
 Logo

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.